Neutropenia

Related records

Broader conditions (8)

• Agranulocytosis
• Disease
• Disease by body system or component
• Hematologic disorder
• Human disease
• Immune system disorder
• Leukocyte disorder
• Leukopenia

Narrower conditions (39)

• Autosomal dominant severe congenital neutropenia
• Autosomal recessive severe congenital neutropenia
• Autosomal recessive severe congenital neutropenia due to CSF3R deficiency
• Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency
• Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency
• Autosomal recessive severe congenital neutropenia due to JAGN1 deficiency
• Barth syndrome
• Chediak-Higashi syndrome
• Cohen syndrome
• Congenital neutropenia-myelofibrosis-nephromegaly syndrome
• Constitutional neutropenia
• Cyclic neutropenia
• ELANE-related neutropenia
• Glycogen storage disease Ib
• Griscelli syndrome type 2
• Hermansky-Pudlak syndrome 2
• Kostmann syndrome
• Lichtenstein syndrome
• Neonatal alloimmune neutropenia
• Neutropenia-monocytopenia-deafness syndrome

Trials (444)

• A Comparative Evaluation of Pharmacokinetics and Immunogenicity.
• A comparatiVe Study on Efficacy and Safety of Lipegfilgrastim in Comparison to Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-HOdgkin Lymphomas at hIgh Risk for R-CHOP-21-inDuced Neutropenia
• A Comparative Study to Evaluate the Effect of HSP-130, US-approved Neulasta and EU-approved Neulasta in Healthy Participants
• A Comparator Study of a Tasso Device Blood Sample to Traditional Venous Blood Sample for CBC
• A Comparison of Fluconazole and Amphotericin B in the Treatment of Fungal Infections
• A Multi-cohort Study of Efbemalenograstim Alfa Injection for Preventing ANC Reduction in Solid Tumor Patients Post Immune-chemotherapy.
• A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection
• A Pharmacokinetics/Dynamics Ib Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy
• A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
• A Phase I/II Pilot Study of Simultaneously Administered Rhu GM-CSF ( CHO Cell ) and Azidothymidine ( AZT ) in Patients With Severe HIV Infection and Leukopenia: Pharmacokinetics and Feasibility
• A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF in Breast Cancer Patients Receiving Chemotherapy
• A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy.
• A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia
• A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine
• A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy
• A Post Marketing Surveillance Study of Lipo-AB® (Amphotericin B) in Neutropenic Patients With Persistent Fever
• A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemotherapy With GM-CSF (Granulocyte-Macrophage Colony-Stimulating Factor) Versus PIXY 321 in Advanced Breast Cancer
• A Randomized, Controlled, Multicenter Trial of Filgrastim (Recombinant-Methionyl Human Granulocyte Colony Stimulating Factor; G-CSF) for the Prevention of Grade 4 Neutropenia in Patients With HIV Infection.
• A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole Vs. AmBisome for Empirical Antifungal Therapy in Immunocompromised Patients With Persistent Fever and Neutropenia
• A Real World Study Evaluating the Clinical Application of PEG-rhG-CSF During Chemotherapy in Patients With Solid Tumors

Approved drugs (5)

• Efbemalenograstim alfa
• Filgrastim
• Lipegfilgrastim
• Pegfilgrastim
• Posaconazole

Drugs in development (73)

• Alcohol Phase 3
• Amoxicillin Phase 3
• Amphotericin B Phase 3
• Anakinra Phase 2
• Anidulafungin Phase 1
• Avibactam Phase 2
• Balugrastim Phase 2
• Carboplatin Phase 2
• Caspofungin Phase 2
• Caspofungin acetate Phase 3
• Cefepime Phase 3
• Cefepime hydrochloride Phase 3
• Ceftazidime Phase 2
• Ceftazidime sodium Phase 2
• Ceftobiprole medocaril free acid Phase 3
• Ceftobiprole medocaril sodium Phase 3
• Ceftolozane Phase 2
• Chlorhexidine Phase 3
• Ciprofloxacin Phase 3
• Cisplatin Phase 2

Other linked drugs (8)

• Amikacin
• Cloxacillin
• Cloxacillin sodium
• Itraconazole
• Meropenem
• Moxifloxacin
• Piperacillin
• Teicoplanin